What was BioNTech SE's revenue in 2024?

BioNTech SE reported $3.0B in revenue for fiscal year 2024. This represents a -27.9% change compared to 2023. The slide continued with a 27.9 percent year-over-year drop, driven by collapsing demand for the Pfizer-partnered Comirnaty COVID-19 vaccine.

How did BioNTech SE's revenue change from 2023 to 2024?

BioNTech SE revenue declined from $4.2B in 2023 to $3.0B in 2024, a change of -27.9%.

Was 2024 BioNTech SE's best revenue year?

No. BioNTech SE's highest recorded revenue year was 2022 at $18.9B. In 2024, BioNTech SE reported $3.0B.

What was BioNTech SE's highest ever annual revenue?

BioNTech SE's highest ever annual revenue was $18.9B recorded in fiscal year 2022.

BioNTech SE

Biotechnology / ImmunotherapyFounded 2008

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.

Annual Revenue

BioNTech SE Revenue in 2024

FY2024 Revenue

$3.0B

▼ 27.9% vs FY2023 ($4.2B)

Source: Annual report / company filing

BioNTech SE reported $3.0B in revenue for fiscal year 2024. This represents a decline of 27.9% compared to the 2023 figure of $4.2B. In 2025, revenue increased to $3.2B.

The slide continued with a 27.9 percent year-over-year drop, driven by collapsing demand for the Pfizer-partnered Comirnaty COVID-19 vaccine.

Revenue by Year

FY2025 FY2024 FY2023 FY2022

BioNTech SE Annual Revenue History

Year	Revenue	YoY Change
FY2025	$3.2B	+5.7%
FY2024	$3.0B	-27.9%
FY2023	$4.2B	-78.0%
FY2022	$18.9B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2023: $4.2B

Next year →

FY2025: $3.2B

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.